ClinicalTrials.Veeva

Menu

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer (TEAL)

Yale University logo

Yale University

Status

Enrolling

Conditions

Ovarian Cancer

Treatments

Behavioral: Exercise and medical nutrition

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05761561
20211179
U01CA271278 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

An anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital Network at Yale Cancer Center (YCC) and Sylvester Comprehensive Cancer Center (SCCC) at University of Miami.

Participants will be randomized to an exercise and medical nutrition intervention arm with weekly counseling sessions throughout chemotherapy, or a control arm.

Study assessments will be conducted at baseline, post-chemotherapy/end of intervention and at 1-year post diagnosis. Women who are prescribed neoadjuvant therapy will have additional assessments prior to surgery.

Data required to calculate the primary endpoint (relative dose intensity of chemotherapy) will be abstracted from the medical record directly following each chemotherapy session.

Full description

200 women with newly diagnosed ovarian or endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital at Yale Cancer Center (YCC) and Sylvester Comprehensive Cancer Center (SCCC) at University of Miami. If women are interested and eligible, the study team will obtain consent and collect baseline data. Participants will be randomized to an exercise and medical nutrition intervention (18 weeks dependent on length of chemotherapy) or usual care throughout therapy. After the standard 6 cycles of chemotherapy (~18 weeks), a post-chemotherapy/end of intervention visit will be conducted. Follow-up assessments will be at standard of care visits (12-months post-diagnosis). Data required to calculate the primary endpoint (relative dose intensity of chemotherapy) will be abstracted from the medical record directly following each chemotherapy session.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • have a diagnosis of epithelial ovarian cancer, fallopian tube or primary peritoneal carcinoma, stage I-IV OR have a diagnosis of advanced or metastatic endometrial carcinoma (including carcinosarcoma) AND their treatment regimen includes carboplatin and taxane (or equivalent)
  • be scheduled to receive at least 6 cycles of neoadjuvant or adjuvant chemotherapy
  • be physically able to walk without a walking aid (e.g. cane or walker)
  • be able to complete forms, understand instructions and read intervention book in English or Spanish
  • agree to be randomly assigned to either group
  • have clearance from oncologist to participate
  • be ≥ 18 years of age

Exclusion criteria

  • having already completed a 2nd cycle of chemotherapy
  • already practicing dietary (>7 servings of fruits and vegetables per day) OR physical activity guidelines (≥150 min per week of moderate to vigorous exercise and resistance training two times per week) since diagnosis
  • pregnancy or intention to become pregnant
  • recent (past year) stroke/myocardial infarction or congestive heart failure/ejection fraction <40%
  • presence of dementia or major psychiatric disease
  • in active treatment including target or biologic therapies for any other cancer (excluding hormone therapy treatments)
  • receiving external beam radiation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

Exercise and medical nutrition
Experimental group
Description:
Over the intervention period (18 weeks on average - dependent on length of chemotherapy) women in the intervention arm will receive weekly counseling sessions, the study dietitian and exercise trainer will each conduct weekly sessions to assist the participants in achieving the diet and exercise study goals.
Treatment:
Behavioral: Exercise and medical nutrition
Control
No Intervention group
Description:
Contact limited to study assessments.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems